[144] Vita Coco Company, Inc. SEC Filing

Rhea-AI Filing Summary

Vita Coco Company, Inc. (COCO) filed a Form 144 reporting insider transactions tied to the sale of common stock. The filing shows 1,000 shares to be sold through Morgan Stanley Smith Barney on 09/15/2025 with an aggregate market value of $39,570. It also discloses a contemporaneous acquisition: the filer exercised options and acquired those 1,000 shares on 09/15/2025 and paid in cash. The filing lists prior 10b5-1 sales by the same person totaling 6,000 shares executed between 09/05/2025 and 09/12/2025 with gross proceeds shown for each trade. The notice includes the required representation that the seller is unaware of undisclosed material adverse information.

Positive

• Disclosure compliance: Form 144 provides required details including acquisition date, broker, sale dates, and aggregate values
• Transparency of trading plan: Prior 10b5-1 sales for the same person are listed, showing adherence to a prearranged plan

Negative

• None.

Insights

Securities Compliance Analyst

TL;DR: Routine insider exercise and sales disclosed under Rule 144 and 10b5-1; filing meets public notice requirements.

The Form 144 provides standard disclosure of an option exercise and proposed sale of 1,000 shares via Morgan Stanley Smith Barney and documents multiple recent 10b5-1 sales totaling 6,000 shares. From a compliance standpoint, the filing contains the key elements: acquisition date, nature of acquisition, sale broker, approximate sale date, and aggregate market values. The representation regarding absence of undisclosed material adverse information is included as required. There is no additional company operational or financial data in this filing to assess broader investor impact.

Financial Analyst

TL;DR: Insider transactions are small relative to outstanding shares and appear routine; limited investment relevance.

The disclosed 1,000-share sale (aggregate value $39,570) and the six prior 1,000-share 10b5-1 sales show modest insider liquidity activity. Given the issuer's reported outstanding shares of 56,822,981, these trades represent a de minimis percentage of float and are unlikely to materially affect valuation or operations. The filing does not include earnings, guidance, or material corporate events; therefore, its informational value is limited to insider trading transparency.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	1000	39570.00	56822981	09/15/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	09/15/2025	Exercise of Stock Options	Issuer			1000	09/15/2025	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for COREY BAKER 250 Park Avenue South, 7th Floor New York NY 10003	Common	09/12/2025	1000	40000.00
10b5-1 Sales for COREY BAKER 250 Park Avenue South, 7th Floor New York NY 10003	Common	09/11/2025	1000	38660.00
10b5-1 Sales for COREY BAKER 250 Park Avenue South, 7th Floor New York NY 10003	Common	09/10/2025	1000	38160.00
10b5-1 Sales for COREY BAKER 250 Park Avenue South, 7th Floor New York NY 10003	Common	09/09/2025	1000	38400.00
10b5-1 Sales for COREY BAKER 250 Park Avenue South, 7th Floor New York NY 10003	Common	09/08/2025	1000	38510.00
10b5-1 Sales for COREY BAKER 250 Park Avenue South, 7th Floor New York NY 10003	Common	09/05/2025	1000	38000.00

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What insider activity does the COCO Form 144 disclose?

The filing discloses the exercise of options and a proposed sale of 1,000 common shares on 09/15/2025 and prior 10b5-1 sales totaling 6,000 shares between 09/05/2025 and 09/12/2025.

Who is the broker handling the proposed sale in the COCO filing?

The proposed sale is to be executed through Morgan Stanley Smith Barney LLC at 1 New York Plaza, New York, NY.

What was the aggregate market value reported for the 1,000 shares to be sold on 09/15/2025?

The Form 144 reports an aggregate market value of $39,570 for the 1,000 shares scheduled for sale on 09/15/2025.

How were the 1,000 shares acquired according to the filing?

The filing states the shares were acquired on 09/15/2025 by exercise of stock options from the issuer, with payment made in cash.

How many shares outstanding does the filing list for the issuer?

The Form 144 lists 56,822,981 shares outstanding for the issuer.